One of the most high-profile offseason signings for the Toronto Blue Jays this past winter, Max Scherzer, only lasted three innings in his first start with his ...

It's the start of a throwing progression for Eflin, who went down with a mild right lat strain one week ago. The veteran right-hander is optimistic his absence won't last long, but a clearer picture ...

Alphabet, the parent company of Google, is named the top large company in the US for growing your career, according to ...

Sloclap’s 5-on-5 arcade-y online soccer game, couldn't be more different than Sifu. But nevertheless, it had a lot to like in ...

A one-year prospective study found no correlation between atherosclerosis and extremely high cholesterol levels in 100 ...

Atlantic is back at it on Tuesday at Harlan's Ken Carsten Relays. They'll head to Abraham Lincoln's meet on Thursday. The ...

How each of the eight quarter-finalists' chances have looked throughout 2024-25, based on The Athletic's Opta-powered ...

The Los Angeles Dodgers are navigating the uncharted territory of a two-way player with Shohei Ohtani. More news: Mookie Betts Gets Honest About Dodgers' Rou ...

The San Antonio Spurs entered the 2024-25 NBA season with hopes of making the playoffs or Play-In Tournament, but Gregg ...

This story was excerpted from Todd Zolecki's Phillies Beat newsletter. To read the full newsletter, click here. And subscribe ...

A recent study has uncovered a potential breakthrough in treating osteonecrosis of the femoral head (ONFH), a debilitating bone disease that causes severe pain and joint collapse.

There's new research linking senolytics to helping slow down Alzheimer's progression. Here's how and what experts have to say ...